ReviewDiabetology & metabolic syndrome2025

Dual-faced guardians: SGLT2 inhibitors' kidney protection and health challenges: a position statement by Kasralainy nephrology group (KANG).

Amin Roshdy Soliman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.